2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theAllergic Rhinitis Market from 2025 to 2034?

The surge in air pollution and climate change is predicted to fuel the growth of the allergic rhinitis industry. The term air pollution refers to the existence of hazardous substances in the atmosphere of the Earth that negatively impact both the environment and human health, as well as the quality of the air we inhale. Climate change denotes long-standing changes in the Earth’s weather patterns, such as alterations in temperature, rainfall, and other weather-related factors. It’s been progressively recognized that air pollution significantly contributes to the occurrence and escalation of allergic rhinitis, emphasizing the complex link between air quality and respiratory health. For example, the United States Environmental Protection Agency stated in August 2024 that nearly 66 million tons of pollutants were emitted into the U.S. atmosphere in 2023. This indicates that the rise in air pollution and climate change fuels the allergic rhinitis market’s growth. A surge in the use of corticosteroids in treating allergic rhinitis is anticipated to propel the allergic rhinitis market forward. The steroid treatment, which includes the use of drugs called corticosteroids, is typically used to treat allergic rhinitis as it aids in reducing inflammation in the nasal passages, thus alleviating symptoms associated with the condition. In September 2023, the American Society for Clinical Pharmacology and Therapeutics reported that the average use of oral corticosteroids was approximately 6.8% in the U.S., 17.5% in Taiwan, and 2.2% in Denmark, with annual increments between 0.1% and 0.17%. Most of these prescriptions were short-term (1–29 days) for healthy adults suffering from transient conditions like respiratory infections. Therefore, the increased use of corticosteroid treatments drives the growth of the allergic rhinitis market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12926&type=smp

How Will the Growth Rate of theAllergic Rhinitis Market Impact Industry Trends by 2034?

The market scale for allergic rhinitis has observed a consistent upward trend in recent years, with a projection to rise from $15.22 billion in 2024 to $15.74 billion in 2025, which denotes a compound annual growth rate (CAGR) of 3.4%. Factors like exposure to allergens, environmental shifts, increased public cognizance, escalating pollution levels, advancements in research and development specific to allergic rhinitis, and growth in disposable incomes can be associated with the historical period’s progression.

The market size for allergic rhinitis is projected to experience consistent upswing in the upcoming years. It is anticipated to expand to $18.49 billion by 2029, growing at a compound annual growth rate (CAGR) of 4.1%. The market’s expansion in the prediction period can be credited to a rising demand for preventive remedies, an aging demographic, urbanization, and healthcare expenditure. Key trends for the anticipated period encompass biologics and monoclonal antibodies, digital healthcare solutions, strategies for avoiding allergens, pediatric allergic rhinitis, and allergen detection technology.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12926

How Are Market Trends and Innovations Revolutionizing theAllergic Rhinitis Industry in Recent Times?

Key players in the market dealing with allergic rhinitis are creating innovative medicinal solutions to maintain market dominance. In August 2022, UK’s Hikma Pharmaceuticals PLC and Switzerland’s Glenmark Specialty S.A., received approval from the United States Food and Drug Administration (FDA) for their product Ryaltris. Ryaltris, the inaugural fixed-dose combination treatment, addresses both nasal and eye symptoms of seasonal allergic rhinitis through a user-friendly nasal spray. It is approved for adults and children aged 12 and above. Remarkably, its nasal relief effect is observed within 15 minutes of the initial dosage.

Which Key Market Players Are Shaping the Future and Growth of theAllergic Rhinitis Market?

Major companies operating in the allergic rhinitis market are Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Limited, Menarini Group, Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Endo Pharmaceuticals Inc., Zydus Lifesciences Ltd., Lupin Limited, Glenmark Pharma Ltd., Almirall S.A., Kyowa Kirin Co. Ltd., Hanmi Pharmaceutical Co. Ltd., Akorn Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report

What Are the Core Segments of the Allergic Rhinitis Market, and How Do They Contribute to Growth?

The allergic rhinitis market covered in this report is segmented –

1) By Type: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis

2) By Treatment: Antihistamines, Corticosteroids, Immunotherapy, Decongestants, Other Treatments

3) By Test: Skin Test, IgE Radioallergosorbent (RAST) Test, Complete Blood Count

4) By Route Of Administration: Oral, Nasal, Other Route Of Administration

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores

Subsegments:

1) By Seasonal Allergic Rhinitis: Pollen Allergy, Mold Allergy

2) By Perennial Allergic Rhinitis: Dust Mite Allergy, Pet Allergy, Mold Allergy

3) By Occupational Allergic Rhinitis: Chemical Allergens, Biological Allergens

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12926&type=smp

What Regions Are Dominating the Allergic Rhinitis Market Growth?

North America was the largest region in the allergic rhinitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Allergic Rhinitis Market 2025, By The Business Research Company:

Allergy Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

Antibiotic Free Meat Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antibiotic-free-meat-global-market-report

Allergy Immunotherapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: